Ventyx Biosciences Inc
NASDAQ:VTYX
Ventyx Biosciences Inc
NASDAQ:VTYX
Price:
13.96
USD
0.07%
Market Cap:
$1B
Balance Sheet
Balance Sheet Decomposition
Ventyx Biosciences Inc
Ventyx Biosciences Inc
Balance Sheet Decomposition is not available for
Ventyx Biosciences Inc
Ventyx Biosciences Inc
Balance Sheet
Ventyx Biosciences Inc
Ventyx Biosciences Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
71
|
65
|
52
|
27
|
|
| Cash Equivalents |
0
|
0
|
71
|
65
|
52
|
27
|
|
| Short-Term Investments |
0
|
0
|
188
|
253
|
201
|
190
|
|
| Other Current Assets |
0
|
0
|
4
|
13
|
12
|
12
|
|
| Total Current Assets |
0
|
0
|
263
|
331
|
264
|
230
|
|
| PP&E Net |
0
|
0
|
0
|
2
|
12
|
10
|
|
| PP&E Gross |
0
|
0
|
0
|
2
|
12
|
10
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
28
|
39
|
0
|
36
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Assets |
0
N/A
|
0
-33%
|
292
+145 650%
|
371
+27%
|
278
-25%
|
277
0%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
1
|
5
|
6
|
6
|
3
|
|
| Accrued Liabilities |
0
|
0
|
8
|
10
|
17
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
12
|
16
|
22
|
13
|
|
| Long-Term Debt |
4
|
3
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
27
|
0
|
1
|
12
|
10
|
|
| Total Liabilities |
5
N/A
|
31
+587%
|
12
-60%
|
18
+42%
|
34
+93%
|
23
-33%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
33
|
118
|
226
|
419
|
554
|
|
| Additional Paid In Capital |
0
|
2
|
397
|
581
|
663
|
808
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Equity |
4
N/A
|
31
-649%
|
279
N/A
|
354
+27%
|
244
-31%
|
254
+4%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-33%
|
292
+145 650%
|
371
+27%
|
278
-25%
|
277
0%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
49
|
49
|
50
|
57
|
59
|
71
|
|
Switch to:
Switch to:
See Also
Discover More
